1. Home
  2. MSLE vs TKNO Comparison

MSLE vs TKNO Comparison

Compare MSLE & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$6.71

Market Cap

146.9M

Sector

N/A

ML Signal

N/A

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$4.00

Market Cap

138.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSLE
TKNO
Founded
N/A
1996
Country
Canada
United States
Employees
17
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.9M
138.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MSLE
TKNO
Price
$6.71
$4.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
29.4K
92.1K
Earning Date
N/A
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.86
EPS
N/A
N/A
Revenue
N/A
$40,520,000.00
Revenue This Year
N/A
$8.27
Revenue Next Year
N/A
$13.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.35
52 Week Low
$5.50
$1.91
52 Week High
$13.39
$6.68

Technical Indicators

Market Signals
Indicator
MSLE
TKNO
Relative Strength Index (RSI) 46.00 63.52
Support Level $6.73 $3.49
Resistance Level $8.59 $4.37
Average True Range (ATR) 0.50 0.34
MACD -0.04 -0.00
Stochastic Oscillator 22.22 57.26

Price Performance

Historical Comparison
MSLE
TKNO

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Share on Social Networks: